newsfilter
← Latest News
GlobeNewswire·

Cyclacel Pharmaceuticals Reports Second Quarter Financial Results and Provides Business Update

- Oral Fadraciclib Phase 2 Proof of Concept Study Enrolling Well -- 065-101 PoC Interim Data Anticipated in the Fourth Quarter of 2024 -- Management to Host Conference Call at 4:30 pm EDT Today - BERKELEY HEIGHTS, N.J.,